Certified Advisory Corp’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $820K | Buy |
6,383
+96
| +2% | +$11.2K | 0.07% | 185 |
|
|
2026
Q1 | $756K | Buy |
6,287
+67
| +1% | +$7.74K | 0.07% | 184 |
|
|
2025
Q4 | $655K | Sell |
6,220
-112
| -2% | -$10.5K | 0.06% | 188 |
|
|
2025
Q3 | $531K | Sell |
6,332
-2
| -0% | -$165 | 0.05% | 200 |
|
|
2025
Q2 | $501K | Buy |
6,334
+485
| +8% | +$38.6K | 0.05% | 200 |
|
|
2025
Q1 | $525K | Sell |
5,849
-499
| -8% | -$46.6K | 0.06% | 187 |
|
|
2024
Q4 | $632K | Sell |
6,348
-55
| -0.9% | -$5.67K | 0.07% | 174 |
|
|
2024
Q3 | $727K | Buy |
6,403
+257
| +4% | +$30.5K | 0.08% | 165 |
|
|
2024
Q2 | $761K | Buy |
6,146
+554
| +10% | +$71.4K | 0.1% | 157 |
|
|
2024
Q1 | $738K | Sell |
5,592
-859
| -13% | -$106K | 0.1% | 148 |
|
|
2023
Q4 | $703K | Sell |
6,451
-15,477
| -71% | -$1.61M | 0.11% | 149 |
|
|
2023
Q3 | $681K | Buy |
21,928
+15,779
| +257% | +$1.7M | 0.13% | 139 |
|
|
2023
Q2 | $710K | Sell |
6,149
-75
| -1% | -$8.52K | 0.13% | 133 |
|
|
2023
Q1 | $662K | Buy |
6,224
+864
| +16% | +$93.3K | 0.12% | 153 |
|
|
2022
Q4 | $595K | Buy |
5,360
+252
| +5% | +$25.8K | 0.12% | 148 |
|
|
2022
Q3 | $440K | Sell |
5,108
-95
| -2% | -$8.48K | 0.1% | 161 |
|
|
2022
Q2 | $474K | Buy |
5,203
+18
| +0.3% | +$1.6K | 0.11% | 152 |
|
|
2022
Q1 | $426K | Buy |
5,185
+20
| +0.4% | +$1.58K | 0.09% | 159 |
|
|
2021
Q4 | $396K | Buy |
5,165
+178
| +4% | +$14.2K | 0.09% | 171 |
|
|
2021
Q3 | $374K | Buy |
4,987
+178
| +4% | +$13.5K | 0.09% | 168 |
|
|
2021
Q2 | $374K | Buy |
4,809
+150
| +3% | +$11.2K | 0.09% | 166 |
|
|
2021
Q1 | $342K | Buy |
+4,659
| New | +$344K | 0.09% | 158 |
|
|
2020
Q2 | $282K | Buy |
3,821
+17
| +0.4% | +$1.28K | 0.09% | 161 |
|
|
2020
Q1 | $279K | Sell |
3,804
-242
| -6% | -$19K | 0.11% | 143 |
|
|
2019
Q4 | $351K | Buy |
4,046
+82
| +2% | +$6.74K | 0.11% | 149 |
|
|
2019
Q3 | $319K | Buy |
3,964
+224
| +6% | +$18K | 0.11% | 151 |
|
|
2019
Q2 | $299K | Sell |
3,740
-59
| -2% | -$4.52K | 0.11% | 145 |
|
|
2019
Q1 | $302K | Buy |
3,799
+64
| +2% | +$4.79K | 0.13% | 130 |
|
|
2018
Q4 | $272K | Sell |
3,735
-147
| -4% | -$10.4K | 0.14% | 119 |
|
|
2018
Q3 | $263K | Buy |
3,882
+11
| +0.3% | +$701 | 0.12% | 134 |
|
|
2018
Q2 | $224K | Buy |
3,871
+120
| +3% | +$6.77K | 0.12% | 132 |
|
|
2018
Q1 | $194K | Buy |
3,751
+308
| +9% | +$16.6K | 0.12% | 142 |
|
|
2017
Q4 | $184K | Buy |
+3,443
| New | +$191K | 0.13% | 118 |
|
Other funds holding MRK
ATO
QP
AAMU
Certified Advisory Corp's MRK Position: Q2 2026 in Review
Certified Advisory Corp increased its Merck (MRK) stake by 1.5% in Q2 2026, buying an estimated $11.2K and bringing the position to 6,383 shares worth $820K. The position accounts for 0.07% of the portfolio, ranked #185.
Certified Advisory Corp first reported a position in MRK in Q4 2017 and has held it in 33 quarters since. 1,411 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Certified Advisory Corp held 6,383 shares of Merck worth $820K as of Q2 2026.
- Certified Advisory Corp bought 96 Merck shares in Q2 2026, an estimated $11.2K.
- Merck made up 0.07% of Certified Advisory Corp's portfolio in Q2 2026, its #185 holding.
- Certified Advisory Corp first reported a position in Merck in Q4 2017 and has held it in 33 quarters since.
- 1,411 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Certified Advisory Corp's 13F filing for Q2 2026, filed 16 Jul 2026.